1. Home
  2. ANY vs IMRN Comparison

ANY vs IMRN Comparison

Compare ANY & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sphere 3D Corp.

ANY

Sphere 3D Corp.

HOLD

Current Price

$0.27

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.96

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANY
IMRN
Founded
N/A
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ANY
IMRN
Price
$0.27
$0.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
441.0K
84.7K
Earning Date
11-04-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,099,000.00
$4,777,422.00
Revenue This Year
N/A
N/A
Revenue Next Year
$29.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.63
52 Week Low
$0.29
$0.68
52 Week High
$1.26
$2.39

Technical Indicators

Market Signals
Indicator
ANY
IMRN
Relative Strength Index (RSI) 31.16 47.84
Support Level $0.32 $1.01
Resistance Level $0.38 $1.13
Average True Range (ATR) 0.03 0.10
MACD 0.00 0.04
Stochastic Oscillator 7.16 51.72

Price Performance

Historical Comparison
ANY
IMRN

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: